Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized Controlled Trial. (July 2020)
- Record Type:
- Journal Article
- Title:
- Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized Controlled Trial. (July 2020)
- Main Title:
- Starch or Saline After Cardiac Surgery: A Double-Blinded Randomized Controlled Trial
- Authors:
- Nagpal, A. Dave
Cowan, Andrea
Li, Linna
Nusca, Graeme
Guo, Linrui
Novick, Richard J.
Harle, Chris C.
House, Andrew A.
Fox, Stephanie
Jones, Philip M. - Abstract:
- Background: Despite decades of investigation, the balance of clinical risks and benefits of fluid supplementation with starch remain unresolved. Patient-centered outcomes have not been well explored in a "real-world" trial in cardiac surgery. Objective: We sought to compare a starch-based fluid strategy with a saline-based fluid strategy in the cardiac surgery patient. Design: A pragmatic blinded randomized controlled trial comparing starch-based with saline-based fluid strategy. Setting: A large tertiary academic center in London Ontario between September 2009 and February 2011. Participants: Patients undergoing planned, isolated coronary revascularization. Measurements: Serum creatinine and patient weight were measured daily postoperatively. Methods: Patients were randomized to receive 6% hydroxyethyl starch (Voluven) or saline for perioperative fluid requirements. Fluid administration was not protocolized. Co-primary outcomes were incidence of acute kidney injury (AKI) and maximum postoperative weight gain. Secondary outcomes included bleeding, transfusion, inotropic and ventilator support, and fluid utilization. Results: The study was prematurely terminated due to resource limitations. A total of 69 patients (19% female, mean age = 65) were randomized. Using RIFLE criteria for AKI, "risk" occurred in 12 patients in each group (risk ratio [RR] = 1.0; 95% confidence interval [CI] = 0.5-1.9; P = 1.00), whereas "injury" occurred in 7 of 35 (20%) and 3 of 34 (9%) of patientsBackground: Despite decades of investigation, the balance of clinical risks and benefits of fluid supplementation with starch remain unresolved. Patient-centered outcomes have not been well explored in a "real-world" trial in cardiac surgery. Objective: We sought to compare a starch-based fluid strategy with a saline-based fluid strategy in the cardiac surgery patient. Design: A pragmatic blinded randomized controlled trial comparing starch-based with saline-based fluid strategy. Setting: A large tertiary academic center in London Ontario between September 2009 and February 2011. Participants: Patients undergoing planned, isolated coronary revascularization. Measurements: Serum creatinine and patient weight were measured daily postoperatively. Methods: Patients were randomized to receive 6% hydroxyethyl starch (Voluven) or saline for perioperative fluid requirements. Fluid administration was not protocolized. Co-primary outcomes were incidence of acute kidney injury (AKI) and maximum postoperative weight gain. Secondary outcomes included bleeding, transfusion, inotropic and ventilator support, and fluid utilization. Results: The study was prematurely terminated due to resource limitations. A total of 69 patients (19% female, mean age = 65) were randomized. Using RIFLE criteria for AKI, "risk" occurred in 12 patients in each group (risk ratio [RR] = 1.0; 95% confidence interval [CI] = 0.5-1.9; P = 1.00), whereas "injury" occurred in 7 of 35 (20%) and 3 of 34 (9%) of patients in the starch and saline groups, respectively (RR = 2.3; 95% CI = 0.6-8.1; P = .31). Maximum weight gain, bleeding and blood product usage, and overall fluid requirement were similar between groups. Limitations: The study had to be prematurely terminated due to resource limitations which led to a small sample size which was not sufficiently powered to detect a difference in the primary outcomes. Conclusions: This pragmatic double-blinded randomized controlled trial revealed a number of interesting hypothesis-generating trends and confirmed the feasibility of undertaking a logistically complex trial in a pragmatic fashion. … (more)
- Is Part Of:
- Canadian journal of kidney health and disease =. Volume 7(2020)
- Journal:
- Canadian journal of kidney health and disease =
- Issue:
- Volume 7(2020)
- Issue Display:
- Volume 7, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 7
- Issue:
- 2020
- Issue Sort Value:
- 2020-0007-2020-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-07
- Subjects:
- fluid therapy -- cardiac surgical procedures -- critical care -- postoperative care
Kidneys -- Diseases -- Periodicals
Nephrology -- Periodicals
Dialysis -- Periodicals
Kidneys -- Transplantation -- Periodicals
Kidney Diseases -- Periodicals
Nephrology -- Periodicals
Dialysis -- Periodicals
Kidney Transplantation -- Periodicals
Dialysis
Kidneys -- Diseases
Kidneys -- Transplantation
Nephrology
Periodicals
Electronic journals
616.61005 - Journal URLs:
- http://bibpurl.oclc.org/web/73266 ↗
http://www.cjkhd.org/ ↗
http://www.uk.sagepub.com/home.nav ↗ - DOI:
- 10.1177/2054358120940434 ↗
- Languages:
- English
- ISSNs:
- 2054-3581
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 14598.xml